IL241653B - Ceramide reversal of multi-drug resistance - Google Patents

Ceramide reversal of multi-drug resistance

Info

Publication number
IL241653B
IL241653B IL241653A IL24165315A IL241653B IL 241653 B IL241653 B IL 241653B IL 241653 A IL241653 A IL 241653A IL 24165315 A IL24165315 A IL 24165315A IL 241653 B IL241653 B IL 241653B
Authority
IL
Israel
Prior art keywords
ceramide
reversal
drug resistance
drug
resistance
Prior art date
Application number
IL241653A
Other languages
Hebrew (he)
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of IL241653B publication Critical patent/IL241653B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL241653A 2013-03-15 2015-09-16 Ceramide reversal of multi-drug resistance IL241653B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361794584P 2013-03-15 2013-03-15
PCT/US2014/028828 WO2014144421A1 (en) 2013-03-15 2014-03-14 Ceramide reversal of multi-drug resistance

Publications (1)

Publication Number Publication Date
IL241653B true IL241653B (en) 2019-08-29

Family

ID=50513497

Family Applications (1)

Application Number Title Priority Date Filing Date
IL241653A IL241653B (en) 2013-03-15 2015-09-16 Ceramide reversal of multi-drug resistance

Country Status (4)

Country Link
US (1) US10052387B2 (en)
EP (1) EP2968143B1 (en)
IL (1) IL241653B (en)
WO (1) WO2014144421A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104922067A (en) * 2014-12-08 2015-09-23 上海张江生物技术有限公司 Drug-loading nano-liposome, and preparation method and application thereof
WO2018005657A1 (en) * 2016-06-28 2018-01-04 Verily Life Sciences Llc Serial filtration to generate small cholesterol-containing liposomes
US11559504B2 (en) * 2017-06-02 2023-01-24 The Penn State Research Foundation Ceramide nanoliposomes, compositions and methods of using for immunotherapy
WO2019090255A1 (en) * 2017-11-03 2019-05-09 University Of Virginia Patent Foundation Compositions and methods for cancer treatment
CN114045294B (en) * 2021-11-22 2023-03-24 昆明理工大学 Lipid transport protein gene and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898735A (en) 1985-12-06 1990-02-06 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Liposome/doxorubicin composition and method
CN1812766A (en) * 2003-04-25 2006-08-02 宾州研究基金会 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
EP1817004A2 (en) * 2004-11-15 2007-08-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Combination therapy associating preferably a ceramide with a cytotoxic drug
WO2009138806A1 (en) * 2008-05-13 2009-11-19 Dendrigen S.A. Novel liposome cocktail formulations containing doxorubicin and the potent multidrug resistance inhibitor amiodarone
US20110177154A1 (en) * 2008-09-15 2011-07-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Tubular nanostructure targeted to cell membrane
WO2012125486A1 (en) * 2011-03-11 2012-09-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Combination chemotherapy for treating cancer
SG2014010409A (en) * 2011-05-10 2014-05-29 Penn State Res Found Ceramide anionic liposome compositions

Also Published As

Publication number Publication date
WO2014144421A1 (en) 2014-09-18
EP2968143B1 (en) 2019-04-24
EP2968143A1 (en) 2016-01-20
US10052387B2 (en) 2018-08-21
US20160184433A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
IL239957B (en) Evaluation and assays of pkal-mediated disorders
PL3466308T3 (en) Stand mixers
SI3038654T1 (en) New use
EP2969742A4 (en) Paddle
GB201305825D0 (en) New use
ZA201604295B (en) Transduction
GB2511101B (en) Torque measurement flexplates
HK1218388A1 (en) Onapristone polymorphic forms and methods of use
IL241653B (en) Ceramide reversal of multi-drug resistance
GB2518713B (en) Water testing
GB2515552B (en) Stand mixers
HK1207641A1 (en) Polymorphic forms of icotinib and uses thereof
TWM475834U (en) Improved structure of glove
GB201306587D0 (en) Adjustable probe
GB2529970B (en) Shower
GB201418411D0 (en) An improved towel
TH1501002710A (en) Seating equipment
TWM475534U (en) Faucet structure
ES1098930Y (en) Mixer tap
TWM475821U (en) Structure of mosquito-catch
TWM475524U (en) Structure of rivet-pulling
GB201301922D0 (en) Resistance
TWM476537U (en) Structure of kettle
ES1098357Y (en) TOWEL
GB201321417D0 (en) Test

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed